BUSINESSCNBC TOP
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS exceeded estimates and raised guidance due to improvements in its insurance unit. The company announced a collaboration with Eli Lilly to make Zepbound and Foundayo accessible to eligible patients via the CVS Health app.
Related Signal
Adjacent reporting
- CVS blows past estimates, hikes outlook as insurance business outperforms
- CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
- CVS Boosts Outlook for 2026 After Aetna Profits Increase
- Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
- CVS Results Beat, Extending Healthcare Win Streak
- Insurance increasingly dropping weight loss drugs like Wegovy, Zepbound